Skip to Main Content

Author Details

Neil Mendhiratta
National Cancer Institute, National Institutes of Health
2013
31
14
PMIDPaper TitleJournal TitlePublished Year
36403677Perioperative Nephrectomy Outcomes for Patients with Liver Disease: Implications for Liver Transplant Candidates.Urology2023
37622756Is prostatic adenocarcinoma with cribriform architecture more difficult to detect on prostate MRI?Prostate2023
37229788Contemporary care patterns in the management of small renal masses.Am J Manag Care2023
36248777Scrotal fibrous hamartoma of infancy: A case report and literature review of a rare tumor of the genitourinary tract.Urol Case Rep2022
37145562Decisional Regret and Financial Toxicity among Patients with Benign Renal Masses.Urol Pract2022
37145547Editorial Commentary.Urol Pract2022
32972793Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) Classifier.Eur Urol2021
34343338Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.Cancer2021
34034966Papillary renal cell carcinoma: Review.Urol Oncol2021
31152197A modified technique for intralesional injection of collagenase Clostridium histolyticum for Peyronie's disease results in reduced procedural morbidity using a standardized hematoma classification rubric.World J Urol2020
31866126Safety of Collagenase Clostridium histolyticum Injection Therapy for Peyronie Disease in Patients Continuing Antiplatelet or Anticoagulant Therapy.J Sex Med2020
30577397PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.J Urol2019
29943220Beyond transrectal ultrasound-guided prostate biopsies: available techniques and approaches.World J Urol2019
30142318PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.J Urol2019
31196763Discontinuation from Collagenase Clostridium histolyticum Therapy for Peyronie's Disease: Review and Single-Center Cohort Analysis.Sex Med Rev2019
29752514Overall survival in patients with residual disease after radical cystectomy and neoadjuvant chemotherapy.World J Urol2018
30222947Editorial Comment.J Urol2018
27562202Risk Stratification by Urinary Prostate Cancer Gene 3 Testing Before Magnetic Resonance Imaging-Ultrasound Fusion-targeted Prostate Biopsy Among Men With No History of Biopsy.Urology2017
26112001Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.Eur Urol2016
27641839The role of MRI in prostate cancer diagnosis and management.Future Oncol2016
27123319AUTHOR'S REPLY.Cent European J Urol2016
27123316Multiparametric MRI and targeted prostate biopsy: Improvements in cancer detection, localization, and risk assessment.Cent European J Urol2016
26800439Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results.BJU Int2016
25495739Detection of third and sixth cranial nerve palsies with a novel method for eye tracking while watching a short film clip.J Neurosurg2015
26414608Using multiparametric MRI to 'personalize' biopsy for men.Curr Opin Urol2015
26335497Prebiopsy MRI and MRI-ultrasound Fusion-targeted Prostate Biopsy in Men With Previous Negative Biopsies: Impact on Repeat Biopsy Strategies.Urology2015
2616381210-Year Mortality After Radical Prostatectomy for Localized Prostate Cancer in the Prostate-specific Antigen Screening Era.Urology2015
26100327Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy in a Consecutive Cohort of Men with No Previous Biopsy: Reduction of Over Detection through Improved Risk Stratification.J Urol2015
25444971Patterns of repeat prostate biopsy in contemporary clinical practice.J Urol2015
25009445Focal laser ablation for localized prostate cancer: principles, clinical trials, and our initial experience.Rev Urol2014
23837967Joint segmentation of anatomical and functional images: applications in quantification of lesions from PET, PET-CT, MRI-PET, and MRI-PET-CT images.Med Image Anal2013
  • 1 - 31 of 31

Recommended Authors

Northwestern University Feinberg School of Medicine
Career Start Year 2013
Number of shared co-authors 2
University of North Carolina School of Medicine
Career Start Year 2012
Number of shared co-authors 13
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 7
Urological Research Institute, IRCCS San Raffaele Hospital
Career Start Year 2012
Number of shared co-authors 0
university of california san diego School of Medicine
Career Start Year 2011
Number of shared co-authors 0
University Hospitals Cleveland Medical Center/Case Western Reserve University
Career Start Year 2011
Number of shared co-authors 9
Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 3
Vanderbilt University Medical Center
Career Start Year 2008
Number of shared co-authors 6
University of Texas Health San Antonio
Career Start Year 2008
Number of shared co-authors 3
University of Oxford
Career Start Year 2007
Number of shared co-authors 1
University of Alberta
Career Start Year 2007
Number of shared co-authors 7
Department of Radiology at the Mayo Clinic Hospital in Phoenix
Career Start Year 2007
Number of shared co-authors 7
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2005
Number of shared co-authors 3
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 6
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 13
Northwestern University
Career Start Year 2003
Number of shared co-authors 6
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 1
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 2
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 7
University of Cambridge
Career Start Year 1999
Number of shared co-authors 1
Erasmus MC Cancer Institute, University Medical Center
Career Start Year 1998
Number of shared co-authors 2
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 1
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 8
Princess Margaret Cancer Center, University Health Network.
Career Start Year 1996
Number of shared co-authors 2
University Health Network
Career Start Year 1995
Number of shared co-authors 4
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 1993
Number of shared co-authors 3
University of Toronto
Career Start Year 1989
Number of shared co-authors 2
University of Melbourne
Career Start Year 1988
Number of shared co-authors 1
Monash University
Career Start Year 1988
Number of shared co-authors 3
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 3

Collaborators

University of California los angeles
Co-authored papers 6
University of California San Diego
Co-authored papers 3
Columbia University Medical Center
Co-authored papers 3
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 2
David Geffen School of Medicine, University of California los angeles
Co-authored papers 2
University of California, Los Angeles David Geffen School of Medicine
Co-authored papers 2
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
Co-authored papers 2
American Medical Informatics Association, IEEE, Johns Hopkins University, Radiological Society of North America, University of California Los Angeles, University of California, Los Angeles
Co-authored papers 2
David Geffen School of Medicine at University of California los angeles
Co-authored papers 2
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Veterans Affairs Palo Alto Healthcare System, Stanford University School of Medicine
Co-authored papers 1
Yale School of Medicine
Co-authored papers 1
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 1
Yale University School of Medicine
Co-authored papers 1
Mount Sinai School of Medicine
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
NYU Grossman School of Medicine
Co-authored papers 1
David Geffen School of Medicine at university of california los angeles
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Baylor Scott and White Health and Texas A&M University College of Medicine
Co-authored papers 1
Institute of Urologic Oncology, University of California Los Angeles
Co-authored papers 1
Co-authored papers 1
Yale University
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1